Nation Mar 09 Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration By Michelle Chapman, Associated Press
Politics Nov 06 WATCH: Trump announces deal to expand coverage, lower costs on obesity drugs President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. By Tom Murphy, Aamer Madhani, JoNel Aleccia, Associated Press
Health Mar 05 Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound The new monthly price of $499, down from $650, takes effect immediately. By Associated Press
Health Sep 24 Watch 3:57 Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face… By William Brangham, Courtney Norris, Ryan Connelly Holmes
Health Mar 14 Novo Nordisk plans major price cuts for several insulins The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30. By Tom Murphy, Associated Press